Having trouble viewing this e-mail? CLICK HERE
Pharm Tech
January 2018
Volume 42, No. 1
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD Twitter LinkedIn

| 2018 BIO/PHARMA OUTLOOK |

Finding the Right Mix for 2018 Bio/Pharma Success

Rita C. Peters

Will business decisions and drug pricing policies help or hinder science and drug approval advances in 2018?
read more

What to Watch for in 2018

Jim Miller

The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
read more

PharmTech January Issue
Download on the app store Read the issue online Subscribe or renew your Pharm Tech subscription

| API SYNTHESIS AND MANUFACTURING |

FDA Ramped Up Approval Rate in 2017

Cynthia A. Challener

FDA looks to achieve near-record level of new drug approvals following slowdown in 2016.
read more


| FORMULATION |

Tackling the Opioid Crisis with Abuse-Deterrent Formulations

Adeline Siew, PhD

Abuse-deterrent opioid formulations generally fall into two categories: the first is based on a physiochemical abuse-deterrent approach and the second combines the opioid with an antagonist.
read more


| FLUID HANDLING |

Selecting and Installing Peristaltic Pump Tubing

Gregg Johnson

Proper selection and installation optimizes fluid system performance.
read more


| INTERNET OF THINGS |

Pharma Equipment Gets Smart

Jennifer Markarian

The Industrial Internet of Things can be used in the bio/pharmaceutical industry to monitor equipment health, optimize processes, and enable modular facilities.
read more


| PEER-REVIEWED RESEARCH |

Removing Subjectivity from the Assessment of Critical Process Parameters and Their Impact

Fasheng Li, Brad Evans, Fangfang Liu, Jingnan Zhang, Ke Wang, Aili Cheng

A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster and less subjective critical process parameter quantification, visualization, and documentation.
read more


| QUALITY |

Process Validation in Biologics Development

Susan Haigney

Process validation is an extension of biologics development processes.
read more


| ELEMENTAL IMPURITIES |

Determination of Dermal PDE for Pharmaceutical Products

Guy Bouvier, Amandine Gras, Jean-Guy Boiteau, Anne-Pascale Luzy, Jean-Pierre Etchegaray

The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
read more


| PACKAGING |

Boosting Functionality of Container Closures

Hallie Forcinio

Closures that protect solid-dosage drugs and the capping equipment that applies them have new product-protecting features.
read more


| PHAMACEUTICAL SERIALIZATION |

Pharma Serialization Nears a Tipping Point

Agnes Shanley

Everyone may not be ready for the deadline, but open standards based on GAMP and GS1 will soon be released; more companies are also leveraging what they've learned from serialization to improve overall efficiency.
read more


| ASK THE EXPERT |

Meeting Data Integrity Requirements

Siegfried Schmitt

Enterprise-wide processes, procedures, and systems are the keys to data integrity and peace of mind, according to Siegfried Schmitt, PhD, principal consultant at PAREXEL.
read more


| FROM THE EDITOR |

New Year, New Questions

Rita C. Peters

Bio/pharma professionals manage expectations amid industry uncertainty.
read more


| Events |

Pharmapack Europe

Feb. 7–8, 2018

IFPAC-2018

Feb. 11–14, 2018

ISPE 2018 Facilities of the Future Conference

Feb. 20–22, 2018


more events

Contribute an article | contact the editors | contact sales | subscribe | advertise